Back to Authors

Schembri Wismayer, Daniel J

Mayo Clinic

Division of Endocrinology, Diabetes & Metabolism, Mayo Clinic College of Medicine, Rochester, Minnesota.

Citations 1

Assessment of individual and standardized glucagon kinetics in healthy humans
LAURENTI, MARCELLO C. , Vella, Adrian , Adams, J.D. , Wismayer, Daniel J. Schembri, Man, Chiara Dalla , Adams, Jon D, Schembri Wismayer, Daniel J, Egan, Aoife M. , Dalla Man, Chiara , Vella, Adrian , Wismayer, Daniel Schembri

American Journal of Physiology-Endocrinology and Metabolism | November 2, 2020 | Volume: 320 | Issue: 1 | Pages: E71-E77

10.1152/ajpendo.00488.2020 Get It

State-of-the-art measurement of insulin secretion in humans is accomplished by deconvolution of peripheral C-peptide concentrations using population-derived parameters of C-peptide kinetics. In contrast, knowledge of the kinetic parameters of glucagon in humans is lacking so that measurement of glucagon secretion to date is largely qualitative. This series of experiments enabled measurement of glucagon kinetics in 51 subjects, and subsequently, stepwise linear regression was used to correlate these parameters with anthropometric characteristics. This enabled the development of a population-based model using anthropometric characteristics to predict the volume of distribution and the rate of clearance. This is a necessary first step in the development of a model to quantitate of glucagon secretion and action (and its contribution to glucose tolerance) in large populations.